| | |
Control
|
Tamsulosin
|
Solifenacin
|
Combined therapy
|
P value
|
|---|
|
Age
|
Mean ± SD
|
38 ± 7
|
39 ± 1
|
40 ± 4
|
39 ± 8
|
0.55
|
|
Sex: n (%)
|
Male
|
21 (53.8)
|
20 (58.8)
|
19 (51.4)
|
18 (54.4)
|
0.37
|
|
Female
|
18 (46.2)
|
14 (41.2)
|
18 (48.6)
|
15 (45.6)
| |
|
Side: n (%)
|
Right
|
19 (48.7)
|
16 (47.1)
|
21 (56.8)
|
20 (60.6)
|
0.09
|
|
Left
|
20 (51.3)
|
18 (52.9)
|
16 (43.2)
|
13 (39.4)
|
|
Indications for stent fixation: n (%)
|
URS
|
27 (69.2)
|
22 (64.7)
|
21(56.8)
|
23 (69.7)
|
0.64
|
|
ESWL
|
8 (20.5)
|
9 (26.5)
|
11(29.7)
|
7 (21.2)
|
|
PNL
|
4 (10.3)
|
3 (8.8)
|
5 (13.5)
|
3 (9.1)
|
|
Stone size (mm) In URS cases
|
Mean ± SD
|
7.7 (1.9)
|
7.4 (1.9)
|
8.1 (2.2)
|
7.8 (1.8)
|
0.12
|
- URS Ureteroscopy, ESWL extracorporeal shock wave lithotripsy, PNL percutaneous nephrolithotomy
